Terms: = Prostate cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO
176 results:
1. PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?
Falkenbach F; Ambrosini F; Kachanov M; Ortner G; Maurer T; Köhler D; Beyersdorff D; Graefen M; Budäus L
World J Urol; 2024 Mar; 42(1):182. PubMed ID: 38506941
[TBL] [Abstract] [Full Text] [Related]
2. Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study.
Pandit AA; Halpern MT; Gressler LE; Kamel M; Payakachat N; Li C
J Geriatr Oncol; 2024 Apr; 15(3):101748. PubMed ID: 38493533
[TBL] [Abstract] [Full Text] [Related]
3. The Impact of Nutrient Supply on prostate cancer Risk Worldwide.
Jiang J; Yang J; Chen B; Li J; Zhang T; Tan D; Tang B; Wei Q
Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140390
[TBL] [Abstract] [Full Text] [Related]
4. Light-responsive smart nanocarriers for wirelessly controlled photodynamic therapy for prostate cancers.
Sun B; Liu J; Kim HJ; Rahmat JNB; Neoh KG; Zhang Y
Acta Biomater; 2023 Nov; 171():553-564. PubMed ID: 37739246
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients.
Paal K; Stranz B; Thurner EM; Langsenlehner U; Renner W; Brunner TB; Langsenlehner T
Strahlenther Onkol; 2024 Mar; 200(3):208-218. PubMed ID: 37658924
[TBL] [Abstract] [Full Text] [Related]
6. Urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in relation to surgeon experience.
Fonseca J; Froes G; Moraes-Fontes MF; Rebola J; Lúcio R; Almeida M; Muresan C; Palmas A; Gaivão A; Matos C; Santos T; Dias D; Sousa I; Oliveira F; Ribeiro R; Lopez-Beltran A; Fraga A
J Robot Surg; 2023 Oct; 17(5):2503-2511. PubMed ID: 37528286
[TBL] [Abstract] [Full Text] [Related]
7. American Indian/Alaska Native men are less likely to receive prostate-specific antigen testing and digital rectal exams from primary care providers than White men: a secondary analysis of the National Ambulatory Medical Care Survey from 2012-2018.
Gillette C; Locklear T; Bell R; Bates N; Ostermann J; Reuland D; Foley K; Lashmit C; Crandall S
Cancer Causes Control; 2023 Sep; 34(9):749-756. PubMed ID: 37217700
[TBL] [Abstract] [Full Text] [Related]
8. Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 prostate cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy.
Chilukuri S; Mallick I; Agrawal A; Maitre P; Arunsingh M; James FV; Kataria T; Narang K; Gurram BC; Anand AK; Utreja N; Dutta D; Pavamani S; Mitra S; Mallik S; Mahale N; Chandra M; Chinnachamy AN; Shahid T; Raghunathan MS; Kannan V; Mohanty SK; Basu T; Hotwani C; Panigrahi G; Murthy V
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):454-462. PubMed ID: 37061457
[TBL] [Abstract] [Full Text] [Related]
9. Intensity-modulated radiation therapy for intermediate-risk prostate cancer: does ADT still have an impact in the dose-escalated external beam radiation therapy era?
Soyano T; Kozuka T; Kashihara K; Murakami Y; Yonese J; Sasamura K; Shimoyachi N; Kashihara T; Yoshioka Y; Oguchi M
Jpn J Clin Oncol; 2023 Jun; 53(6):514-521. PubMed ID: 36946312
[TBL] [Abstract] [Full Text] [Related]
10. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
[TBL] [Abstract] [Full Text] [Related]
11. Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases.
Yuan S; Wang L; Zhang H; Xu F; Zhou X; Yu L; Sun J; Chen J; Ying H; Xu X; Yu Y; Spiliopoulou A; Shen X; Wilson J; Gill D; Theodoratou E; Larsson SC; Li X
EBioMedicine; 2023 Mar; 89():104488. PubMed ID: 36842216
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
13. Association of Neighborhood Deprivation With prostate cancer and Immune Markers in African American and European American Men.
Pichardo MS; Minas TZ; Pichardo CM; Bailey-Whyte M; Tang W; Dorsey TH; Wooten W; Ryan BM; Loffredo CA; Ambs S
JAMA Netw Open; 2023 Jan; 6(1):e2251745. PubMed ID: 36662526
[TBL] [Abstract] [Full Text] [Related]
14. Milk consumption and risk of twelve cancers: A large-scale observational and Mendelian randomisation study.
Lumsden AL; Mulugeta A; Hyppönen E
Clin Nutr; 2023 Jan; 42(1):1-8. PubMed ID: 36473423
[TBL] [Abstract] [Full Text] [Related]
15. Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers.
Liu Q; Reed M; Zhu H; Cheng Y; Almeida J; Fruhbeck G; Ribeiro R; Hu P
Genomics; 2022 Sep; 114(5):110474. PubMed ID: 36057424
[TBL] [Abstract] [Full Text] [Related]
16. Why arnt prostate Tumors Responding to Enzalutamide?
Zhang M; Moreno-Rodriguez T; Quigley DA
Cancer Discov; 2022 Sep; 12(9):2017-2019. PubMed ID: 36052502
[TBL] [Abstract] [Full Text] [Related]
17. Estimation of the Number of Individuals Living With Metastatic cancer in the United States.
Gallicchio L; Devasia TP; Tonorezos E; Mollica MA; Mariotto A
J Natl Cancer Inst; 2022 Nov; 114(11):1476-1483. PubMed ID: 35993614
[TBL] [Abstract] [Full Text] [Related]
18. One-Step Thermophoretic AND Gate Operation on Extracellular Vesicles Improves Diagnosis of prostate cancer.
Deng J; Zhao S; Li J; Cheng Y; Liu C; Liu Z; Li L; Tian F; Dai B; Sun J
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202207037. PubMed ID: 35749531
[TBL] [Abstract] [Full Text] [Related]
19. Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes.
Carter J; Abu-Rustum NR; Saban S; Chen LY; Vickers AJ; Tin AL; Billanti G; Connors NA; Broach V; Brown CL; Chi DS; Gardner GJ; Goldfrank DJ; Jewell EL; Leitao MM; Long Roche KC; Mueller JJ; Sonoda Y; Zivanovic O
JCO Clin Cancer Inform; 2022 Feb; 6():e2100154. PubMed ID: 35239413
[TBL] [Abstract] [Full Text] [Related]
20. Methods and implementation of a Hospital-Based cancer Registry in a major city in a low-to middle-income country: the case of Cali, Colombia.
Parra-Lara LG; Mendoza-Urbano DM; Zambrano ÁR; Valencia-Orozco A; Bravo-Ocaña JC; Bravo-Ocaña LE; Rosso F
Cancer Causes Control; 2022 Mar; 33(3):381-392. PubMed ID: 35013914
[TBL] [Abstract] [Full Text] [Related]
[Next]
